Rithea Leang1, Naw Htee Khu2, Mavuto Mukaka2,3, Mark Debackere4, Rupam Tripura2, Soy Ty Kheang5, Say Chy5, Neeraj Kak6, Philippe Buchy7, Arnaud Tarantola7, Didier Menard7, Arantxa Roca-Felterer8, Rick M Fairhurst9, Sim Kheng1, Sinoun Muth1, Song Ngak10, Arjen M Dondorp2,3, Nicholas J White2,3, Walter Robert John Taylor11,12,13. 1. National Center for Parasitology, Entomology and Malaria Control, Corner St. 92, Trapeng Svay Village, Sangkat Phnom Penh, Thmei, Khan Sen Sok, Phnom Penh, Cambodia. 2. Mahidol Oxford Tropical Medicine Research Unit (MORU), 420/6 Rajvithi Road, Rajthevee, Bangkok, 10400, Thailand. 3. Oxford Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine Research Building, University of Oxford, Old Road Campus, Roosevelt Drive, Oxford, OX3 7FZ, UK. 4. MSF Belgium Cambodia Malaria Program, #19, Street 388, Sangkat Tuol Svay Prey, Khan Chamkarmon, PO Box 1933, Phnom Penh, Cambodia. 5. University Research Co., LLC, MK Building, House #10 (2nd floor), St. 214, Chey Chumneas, Daun Penh, Phnom Penh, Cambodia. 6. University Research Co., LLC Washington DC: 7200 Wisconsin Ave, Bethesda, MD, 20814, USA. 7. Institut Pasteur du Cambodge, 5 Monivong Boulevard, PO Box 983, Phnom Penh, 12201, Cambodia. 8. Malaria Consortium, House #91 Street 95, Boeung Trabek, Chamkar Morn, Phnom Penh, Cambodia. 9. Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, 20852, USA. 10. FHI 360 Cambodia Office, #03, Street 330 Boeung Keng Kang III Khan Chamkamon, PO Box: 2586, Phnom Penh, Cambodia. 11. Mahidol Oxford Tropical Medicine Research Unit (MORU), 420/6 Rajvithi Road, Rajthevee, Bangkok, 10400, Thailand. bob@tropmedres.ac. 12. Oxford Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine Research Building, University of Oxford, Old Road Campus, Roosevelt Drive, Oxford, OX3 7FZ, UK. bob@tropmedres.ac. 13. Centre de Médecine Humanitaire, Hôpitaux Universitaires de Genève, Genève, Switzerland. bob@tropmedres.ac.
After publication of the original article [1], it came to the authors’ attention that there was an error in the PQ pharmacokinetics sub-section of the Background section. The following sentence is affected:“There is no PK interaction between PQ and either artesunate-pyronaridine [76] or mefloquine [69, 77]; no PK interaction data exist for PQ and artemether-lumefantrine (AL).”This sentence should have read as follows:“AS pyronaridine increased PQ exposure by 15% without affecting significantly cPQ exposure [76]. There is no PK interaction between PQ and mefloquine [69, 77]; no PK interaction data exist for PQ and artemether-lumefantrine (AL).”
Authors: Rithea Leang; Naw Htee Khu; Mavuto Mukaka; Mark Debackere; Rupam Tripura; Soy Ty Kheang; Say Chy; Neeraj Kak; Philippe Buchy; Arnaud Tarantola; Didier Menard; Arantxa Roca-Felterer; Rick M Fairhurst; Sim Kheng; Sinoun Muth; Song Ngak; Arjen M Dondorp; Nicholas J White; Walter Robert John Taylor Journal: BMC Med Date: 2016-10-27 Impact factor: 8.775